Literature DB >> 22002478

Use of enteral nutrition for the control of intestinal inflammation in pediatric Crohn disease.

Jeff Critch1, Andrew S Day, Anthony Otley, Cynthia King-Moore, Jonathan E Teitelbaum, Harohalli Shashidhar.   

Abstract

Exclusive enteral nutrition is an effective yet often underused therapy for the induction of remission in pediatric Crohn disease. The North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition formed the Enteral Nutrition Working Group to review the use of enteral nutrition therapy in pediatric Crohn disease. The group was composed of 5 pediatric gastroenterologists and 1 pediatric nutritionist, all with an interest and/or expertise in exclusive enteral nutrition. Specific attention was placed upon review of the evidence for efficacy of therapy, assessment of the variations in care, identification of barriers to its widespread use, and compilation of the necessary components for a successful program. The present guideline is intended to aid physicians in developing an enteral nutrition therapy program and potentially promote its use.

Entities:  

Mesh:

Year:  2012        PMID: 22002478     DOI: 10.1097/MPG.0b013e318235b397

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  49 in total

Review 1.  Exclusive enteral nutrition in children with Crohn's disease.

Authors:  Andrew S Day; Robert N Lopez
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

2.  Toward enteral nutrition for the treatment of pediatric Crohn disease in Canada: a workshop to identify barriers and enablers.

Authors:  Johan Van Limbergen; Jennifer Haskett; Anne M Griffiths; Jeff Critch; Hien Huynh; Najma Ahmed; Jennifer C deBruyn; Robert Issenman; Wael El-Matary; Thomas D Walters; Cheryl Kluthe; Marie-Eve Roy; Elizabeth Sheppard; Wallace V Crandall; Stan Cohen; Frank M Ruemmele; Arie Levine; Anthony R Otley
Journal:  Can J Gastroenterol Hepatol       Date:  2015-06-15

3.  Diet to the Rescue: Cessation of Pharmacotherapy After Initiation of Exclusive Enteral Nutrition (EEN) Followed by Strict and Liberalized Specific Carbohydrate Diet (SCD) in Crohn's Disease.

Authors:  Warapan Nakayuenyongsuk; Megan Christofferson; Kaylie Nguyen; Jennifer Burgis; K T Park
Journal:  Dig Dis Sci       Date:  2017-10       Impact factor: 3.199

4.  Long-term efficacy of enteral nutrition for patients with Crohn's disease.

Authors:  Takayuki Yamamoto; Manabu Shiraki
Journal:  Dig Dis Sci       Date:  2012-10-21       Impact factor: 3.199

Review 5.  Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation Approaches.

Authors:  Abigail R Basson; Minh Lam; Fabio Cominelli
Journal:  Gastroenterol Clin North Am       Date:  2017-12       Impact factor: 3.806

Review 6.  The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions.

Authors:  Stephen M Vindigni; Timothy L Zisman; David L Suskind; Christopher J Damman
Journal:  Therap Adv Gastroenterol       Date:  2016-04-19       Impact factor: 4.409

Review 7.  Use of exclusive enteral nutrition in adults with Crohn's disease: a review.

Authors:  Catherine L Wall; Andrew S Day; Richard B Gearry
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

Review 8.  Diagnosis and management of inflammatory bowel disease in children.

Authors:  Stephanie B Oliveira; Iona M Monteiro
Journal:  BMJ       Date:  2017-05-31

Review 9.  Treatment of IBD: where we are and where we are going.

Authors:  Charles N Bernstein
Journal:  Am J Gastroenterol       Date:  2014-12-09       Impact factor: 10.864

10.  Time to Relapse in Children with Crohn's Disease Treated with Azathioprine and Nutritional Therapy or Corticosteroids.

Authors:  Ondrej Hradsky; Ivana Copova; Kristyna Zarubova; Jiri Nevoral; Jiri Bronsky
Journal:  Dig Dis Sci       Date:  2016-03-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.